6 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
TOWARDS SAFE AND EFFECTIVE IMMUNOTHERAPY OF PERSISTENT LIFE-THREATENING FOOD ALLERGIES (FAST)
Date du début: 1 sept. 2008, Date de fin: 31 mai 2017,
The FAST project aims at the development of safe and effective treatment of food allergies. It targets persistent and severe allergy to fish and fruit. Besides persistence and severity, this choice is based on prevalence and the importance of these foods for a healthy diet. Classical allergen-specific immunotherapy (SIT) for treatment of food allergy using subcutaneous injections with food extract ...
Voir le projet
19
Participants partenaires
TERMINÉ
Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk (ABIRISK)
Date du début: 1 mars 2012, Date de fin: 28 févr. 2017,
The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique panel of experts from different disciplines. ABIRISK will involve many of the European leaders in rheumatology, gastroenterology, hemophilia and multiple sclerosis, caring for ~30,000 patients treated with biopharmaceuticals, with ~10,000 additional patients recru ...
Voir le projet
39
Participants partenaires
TERMINÉ
The Dynamic Protein Matrix in Photosynthesis: From Disorder to Life (PHOTPROT)
Date du début: 1 févr. 2011, Date de fin: 31 janv. 2017,
In photosynthesis solar light is harvested by an antenna, the energy is transferred to the photosynthetic reaction center where a charge separation occurs. These processes occur on an ultrafast timescale and result in a stable product. The photosynthetic apparatus consists of a complex set of pigment-proteins that perform these delicate processes with a quantum efficiency close to 1. Proteins are ...
Voir le projet
3
Participants partenaires
TERMINÉ
Kinetoplastid Drug Development: strengthening the preclinical pipeline (KINDRED)
Date du début: 1 sept. 2013, Date de fin: 31 août 2016,
The trypanosomatid diseases, leishmaniasis, Human African trypanosomiasis (HAT) and Chagas disease (CD), continue to impart a heavy toll on human health. The treatments available are limited and threatened by drug resistance with few newdrugs in the pipeline. The KINDReD consortium integrates five leading academic laboratories in Europe (Portugal, United Kingdom, and Switzerland), the USA (Califor ...
Voir le projet
14
Participants partenaires
TERMINÉ
TERPENOYLATION: AN ORIGINAL CONCEPT FOR THE DISCOVERY OF NEW NANOMEDICINES (TERNANOMED)
Date du début: 1 juin 2010, Date de fin: 31 mai 2015,
Terpenoids are a group of natural compounds that are extraordinary diverse in chemistry, structure and function. Most of the natural terpenoids are flexible and biocompatible biopolymers, having physico-chemical characteristics able to adapt to a wide variety of biologically active compounds. Surprisingly, they have never been used previously in the nanotechnology field for drug delivery and targe ...
Voir le projet
4
Participants partenaires
TERMINÉ
Reactive oxygen species production and reactive oxygen species mediated signalling (ROS signal)
Date du début: 1 sept. 2008, Date de fin: 31 août 2010,
Oxygen plays the important role not only in respiration of the organisms. The interaction of oxygen molecules with cell components produces the reactive oxygen species (ROS). ROS is always present in biological cells and their concentration is maintained in continuous level under normal conditions. But the level of ROS increases significantly under stress conditions which may leads to the cells de ...
Voir le projet